Background <p>Granzyme K (GZMK) is a serine protease known for its perforin-dependent cytotoxicity. However, the non-cytotoxic role of GZMK in lung adenocarcinoma (LUAD) remains largely elusive.</p> Methods <p>Multiomics datasets were integrated to investigate the clinical relevance of GZMK and its association with programmed death-ligand 1 (PD-L1) in LUAD. Recombinant human GZMK (rhGzmK) was applied in tumor-CD8<sup>+</sup> T cell co-culture systems,…
Extracellular granzyme K enhances PD-L1 transcription and stability via F2RL1 activation to facilitate tumor immune evasion in lung adenocarcinoma
Journal for ImmunoTherapy of Cancer | | Feng, H.-M., Zhao, Y., Zhai, K.-R., Li, B., Song, T.-N., Meng, Y.-Q., Huang, H.-R., Li, Z., Cui, B.-Q., Yang, N., Su, Z.-P.
Topics: cervical-cancer, immunotherapy, chemotherapy
Read the full article at Journal for ImmunoTherapy of Cancer